BTS 54-505 hydrochloride
Cat. No. 2322
Chemical Name: 1-(4-Chlorophenyl)-α-(2-methylpropyl
Biological ActivityPotently active primary amine metabolite of sibutramine (Cat. No. 2290), exhibits a similar pharmacological profile to the parent compound. Inhibits serotonin and noradrenalin reuptake more potently than sibutramine in vitro. Reduces food intake in rodents following i.c.v. administration and increases energy expenditure via thermogenesis in vivo.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Safety Data Sheet
Liu et al (2002) Mechanism of the thermogenic effect of Metabolite 2 (BTS 54 505), a major pharmacologically active metabolite of the novel anti-obesity drug, sibutramine. Int.J.Obes.Relat.Metab.Disord. 26 1245. PMID: 12187403.
Gundlah et al (1997) In vivo criteria to differentiate monoamine reuptake inhibitors from releasing agents: sibutramine is a reuptake inhibitor. J.Pharmacol.Exp.Ther. 283 581. PMID: 9353373.
Luscombe et al (1989) The contribution of metabolites to the rapid and potent down-regulation of rat cortical beta-adrenoceptors by the putative antidepressant sibutramine hydrochloride. Neuropharmacology 28 129. PMID: 2541365.
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses BTS 54-505 hydrochloride from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: BTS 54-505 hydrochloride, supplier, Potent, SNRI, active, metabolite, sibutramine, Noradrenaline, Transporter, NET, Adrenergic, Transporters, Monoamine, Neurotransmitter, Serotonin, SERT, 5-HT, reuptake, 5-Hydroxytryptamine, BTS54-505, hydrochloride, Tocris Bioscience, 5-HT Transporter Inhibitor products
Find multiple products by catalog number
New Products in this Area
High affinity and selective presynaptic choline transporter (CHT) inhibitor
Follow Tocris on LinkedIn
Visit our LinkedIn page for the latest Tocris news, events and updates.